secwatch.observer — SEC 8-K summary
======================================

Issuer:     Axsome Therapeutics, Inc. (AXSM)
CIK:        0001579428
Form:       8-K
Filed at:   2025-06-09T23:59:59+00:00
Accession:  0000950170-25-083793
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Axsome stockholders approve all four proposals at 2025 annual meeting
---------------------------------------------------------------------

- Elected Roger A. Jeffs as Class I director with 27.3M votes for, 8.1M withheld.
- Approved 2025 Long-Term Incentive Plan with 26.4M for, 8.9M against.
- Ratified Deloitte & Touche as auditor for FY2025 with 40.8M for, 225.7K against.
- Advisory say-on-pay passed with 34.8M for, 528.2K against.
- Approximately 84% of shares (41.4M of 49.2M) represented at meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1579428/000095017025083793/0000950170-25-083793-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1579428/000095017025083793/axsm-20250606.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-083793

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer